edoc

Items where Author is "Price, Karen N."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2012 | 2011 | 2010 | 2009 | 2008
Number of items: 15.

2012

Chirgwin, Jacquie and Sun, Zhuoxin and Smith, Ian and Price, Karen N. and Thürlimann, Beat and Ejlertsen, Bent and Bonnefoi, Hervé and Regan, Meredith M. and Goldhirsch, Aron and Coates, Alan S. and International Breast Cancer Study Groups, . (2012) The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast cancer research and treatment, Vol. 131, H. 1. pp. 295-306.

2011

Colleoni, Marco and Giobbie-Hurder, Anita and Regan, Meredith M. and Thürlimann, Beat and Mouridsen, Henning and Mauriac, Louis and Forbes, John F. and Paridaens, Robert and Láng, István and Smith, Ian and Chirgwin, Jacquie and Pienkowski, Tadeusz and Wardley, Andrew and Price, Karen N. and Gelber, Richard D. and Coates, Alan S. and Goldhirsch, Aron. (2011) Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study. Journal of clinical oncology, Vol. 29, H. 9. pp. 1117-1124.

Regan, Meredith M. and Neven, Patrick and Giobbie-Hurder, Anita and Goldhirsch, Aron and Ejlertsen, Bent and Mauriac, Louis and Forbes, John F. and Smith, Ian and Láng, István and Wardley, Andrew and Rabaglio, Manuela and Price, Karen N. and Gelber, Richard D. and Coates, Alan S. and Thürlimann, Beat and International Breast Cancer Study Group, . (2011) Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. The Lancet oncology, Vol. 12, H. 12. pp. 1101-1108.

Phillips, Kelly-Anne and Aldridge, Julie and Ribi, Karin and Sun, Zhuoxin and Thompson, Alastair and Harvey, Vernon and Thürlimann, Beat and Cardoso, Fatima and Pagani, Olivia and Coates, Alan S. and Goldhirsch, Aron and Price, Karen N. and Gelber, Richard D. and Bernhard, Jürg. (2011) Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast cancer research and treatment, Vol. 126, H. 1. pp. 221-226.

Regan, Meredith M. and Price, Karen N. and Giobbie-Hurder, Anita and Thürlimann, Beat and Gelber, Richard D. and International Breast Cancer Study Group, . (2011) Interpreting Breast International Group (BIG) 1-98 : a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast cancer research, Vol. 13, H. 3. p. 209.

2010

Paridaens, Robert J. and Gelber, Shari and Cole, Bernard F. and Gelber, Richard D. and Thürlimann, Beat and Price, Karen N. and Holmberg, Stig B. and Crivellari, Diana and Coates, Alan S. and Goldhirsch, Aron. (2010) Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer. Breast cancer research and treatment, Vol. 123, H. 1. pp. 303-310.

Phillips, Kelly-Anne and Ribi, Karin and Sun, Zhuoxin and Stephens, Alisa and Thompson, Alastair and Harvey, Vernon and Thürlimann, Beat and Cardoso, Fatima and Pagani, Olivia and Coates, Alan S. and Goldhirsch, Aron and Price, Karen N. and Gelber, Richard D. and Bernhard, Jürg. (2010) Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. The breast, Vol. 19, H. 5. pp. 388-395.

2009

Pagani, Olivia and Gelber, Shari and Simoncini, Edda and Castiglione-Gertsch, Monica and Price, Karen N. and Gelber, Richard D. and Holmberg, Stig B. and Crivellari, Diana and Collins, John and Lindtner, Jurij and Thürlimann, Beat and Fey, Martin F. and Murray, Elizabeth and Forbes, John F. and Coates, Alan S. and Goldhirsch, Aron. (2009) Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast cancer research and treatment, Vol. 116. pp. 491-500.

Thürlimann, Beat and Price, Karen N. and Gelber, Richard D. and Holmberg, Stig B. and Crivellari, Diana and Colleoni, Marco and Collins, John and Forbes, John F. and Castiglione-Gertsch, Monica and Coates, Alan S. and Goldhirsch, Aron. (2009) Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93. Breast cancer research and treatment, Vol. 113. pp. 137-144.

Mouridsen, Henning and Giobbie-Hurder, Anita and Goldhirsch, Aron and Thürlimann, Beat and Paridaens, Robert and Smith, Ian and Mauriac, Louis and Forbes, John F. and Price, Karen N. and Regan, Meredith M. and Gelber, Richard D. and Coates, Alan S.. (2009) Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. The New England journal of medicine, Vol. 361. pp. 766-776.

Pagani, Olivia and Price, Karen N. and Gelber, Richard D. and Castiglione-Gertsch, Monica and Holmberg, Stig B. and Lindtner, Jurij and Thürlimann, Beat and Collins, John and Fey, Martin F. and Coates, Alan S. and Goldhirsch, Aron. (2009) Patterns of recurrence of early breast cancer according to estrogen receptor status : a therapeutic target for a quarter of a century. Breast cancer research and treatment, Vol. 117. pp. 319-324.

2008

Rasmussen, Birgitte B. and Regan, Meredith M. and Lykkesfeldt, Anne E. and Dell'Orto, Patrizia and Del Curto, Barbara and Henriksen, Katrine L. and Mastropasqua, Mauro G. and Price, Karen N. and Méry, Eliane and Lacroix-Triki, Magali and Braye, Stephen and Altermatt, Hans J. and Gelber, Richard D. and Castiglione-Gertsch, Monica and Goldhirsch, Aron and Gusterson, Barry A. and Thürlimann, Beat and Coates, Alan S. and Viale, Giuseppe. (2008) Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial. The Lancet oncology, Vol. 9. pp. 23-28.

Pestalozzi, Bernhard C. and Zahrieh, David and Mallon, Elizabeth and Gusterson, Barry A. and Price, Karen N. and Gelber, Richard D. and Holmberg, Stig B. and Lindtner, Jurij and Snyder, Raymond and Thürlimann, Beat and Murray, Elizabeth and Viale, Giuseppe and Castiglione-Gertsch, Monica and Coates, Alan S. and Goldhirsch, Aron. (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast : combined results of 15 International Breast Cancer Study Group clinical trials. Journal of clinical oncology, Vol. 26. pp. 3006-3014.

Crivellari, Diana and Sun, Zhuoxin and Coates, Alan S. and Price, Karen N. and Thürlimann, Beat and Mouridsen, Henning and Mauriac, Louis and Forbes, John F. and Paridaens, Robert J. and Castiglione-Gertsch, Monica and Gelber, Richard D. and Colleoni, Marco and Láng, István and Del Mastro, Lucia and Gladieff, Laurence and Rabaglio, Manuela and Smith, Ian E. and Chirgwin, Jacquie H. and Goldhirsch, Aron. (2008) Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer : the BIG 1-98 trial. Journal of clinical oncology, Vol. 26. pp. 1972-1979.

Viale, Giuseppe and Giobbie-Hurder, Anita and Regan, Meredith M. and Coates, Alan S. and Mastropasqua, Mauro G. and Dell'Orto, Patrizia and Maiorano, Eugenio and MacGrogan, Gaëtan and Braye, Stephen G. and Ohlschlegel, Christian and Neven, Patrick and Orosz, Zsolt and Olszewski, Wojciech P. and Knox, Fiona and Thürlimann, Beat and Price, Karen N. and Castiglione-Gertsch, Monica and Gelber, Richard D. and Gusterson, Barry A. and Goldhirsch, Aron. (2008) Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer : results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. Journal of clinical oncology, Vol. 26. pp. 5569-5575.

This list was generated on Fri Mar 29 10:32:36 2024 CET.